143
Participants
Start Date
May 15, 2024
Primary Completion Date
March 6, 2025
Study Completion Date
December 31, 2025
TOUR006 - 50 MG
TOUR006 50 MG
TOUR006 - 25 MG
TOUR006 25 MG
TOUR006 - 15 MG
TOUR006 15 MG
Placebo
Placebo
Site - 0130, Middletown
Site - 0132, Bethlehem
Site - 0109, Manassas
Site - 0147, Morgantown
Site - 0137, Kingwood
Site - 0110, Charlotte
Site - 0103, Greenville
Site - 0102, Fort Mill
Site - 0118, Rock Hill
Site - 0122, Savannah
Site - 0119, Port Orange
Site - 0149, Pembroke Pines
Site - 0144, Plantation
Site - 0142, Boca Raton
Site - 0151, Tampa
Site - 0101, Birmingham
Site - 0135, Huntsville
Site - 0145, Huntsville
Site - 0108, Knoxville
Site - 0127, Marion
Site - 0120, Cincinnati
Site - 0140, Saint Clair Shores
Site - 0114, Council Bluffs
Site - 0134, Kenosha
Site - 0117, Fargo
Site - 0106, Chicago
Site - 0115, Morton
Site - 0129, Metairie
Site - 0150, McKinney
Site - 0148, Greenville
Site - 0111, Lampasas
Site - 0105, Houston
Site - 0107, San Antonio
Site - 0141, San Antonio
Site - 0104, Phoenix
Site - 0123, Las Vegas
Site - 0112, Valencia
Site - 0128, Valencia
Site - 0125, San Dimas
Site - 0113, Greenacres City
Site - 0136, Stamford
Site - 0126, Providence
Tourmaline Bio, Inc.
INDUSTRY